Becton, Dickinson and Company (LON:0R19)

Market Cap	38.72B
Revenue (ttm)	16.25B
Net Income (ttm)	1.25B
Shares Out	n/a
EPS (ttm)	4.33
PE Ratio	31.01
Forward PE	11.91
Dividend	3.15 (1.80%)
Ex-Dividend Date	Sep 8, 2025

Volume	1,235
Average Volume	813
Open	177.22
Previous Close	175.34
Day's Range	175.38 - 178.72
52-Week Range	162.29 - 251.08
Beta	0.30
RSI	35.58
Earnings Date	Nov 6, 2025

About LON:0R19

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1897
• Employees: 70,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R19

Financial Performance

In 2025, LON:0R19's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD